2005 Prague - European Society of Human Genetics

More documents

Recommendations

Info

Exhibition Exhibition Organiser Name ROSE INTERNATIONAL Exhibition Management & Congress Consultancy bv Address P.O. Box 93260 NL-2509 AG The Hague The Netherlands Contact Jantie de Roos Telephone +31 70 383 89 01 Fax +31 70 381 89 36 E-mail eshg@rose-international.com Exhibition Dates & Opening Hours Saturday, 7 May 20.00 – 21.30 hrs - Welcome Reception Sunday, 8 May 08.30 – 20.00 hrs - 18.30 hrs: Wine and Cheese Monday, 9 May 08.30 – 18.30 hrs Tuesday, 10 May 08.30 – 14.00 hrs Exhibition Location Venue Prague Congress Centre – PCC Exhibition Area Foyers 2 nd floor and Forum Hall Address 5. kvĕtna 65 140 21 Prague 4, Czech Republic Telephone + 420 2 61 178 242 Fax + 420 2 61 172 016 Website www.kcp.cz 31
Exhibition Floor Plan Company name Stand Abbott B-328 ABgene C-400 Affymetrix C-474 Agilent Technologies B-300 Agowa A-152 Ambion (Europe) B-342 Applied Biosystems C-510 Applied Spectral Imaging C-404 Asco-Med A-180 BD Biosciences B-316 Biocomputing Platforms C-424 BioGlobe A-120 Biological Industries A-180 BioMarin Pharmaceutical C-466 BioView B-372 BlueGnome B-338 Chemagen Biopolymer Technologie B-306 Coriell Institute for Medical Research A-184 Cytocell Technologies B-318 deCODE genetics C-412 32 Company name Stand Deerac Fluidics A-176 DNA Genotek A-104 ECACC - European Collection of Cell Cultures C-492 ECARUCA - European Cytogeneticists Association Register of Unbalanced Chromosome Aberrations C-506 EGAN - European Genetic Alliance’s Network C-548 Elchrom Scientific A-112 Elsevier B-312 Enzo Life Sciences A-102 ESHG - European Society of Human Genetics C-504 Euroclone A-172 Eurogentec A-168 GE Healthcare C-484 Genevac C-420 Genial Genetic Solutions B-334 Genomed A-116 Genomic Solutions A-108 Gentra Systems C-45 Genzyme C-480 IBM Corporation C-408
Page 1 and 2: The Official Journal of the Europea
Page 3 and 4: Table of Contents Welcoming Address
Page 5 and 6: Acknowledgements 4 The European Hum
Page 7 and 8: Floor Plan Ground Floor First Floor
Page 9 and 10: Programme at a Glance Saturday, May
Page 11 and 12: Scientific Programme Saturday, May
Page 13 and 14: Scientific Programme Sunday, May 8,
Page 15 and 16: Scientific Pogramme Monday, May 9,
Page 17 and 18: ESHG Scientific Pogramme - Tuesday,
Page 19 and 20: Scientific Pogramme Tuesday, May 10
Page 21 and 22: Workshops As submitted by the organ
Page 23 and 24: Satellite Meetings Sunday, 8 May 20
Page 25 and 26: Business and Adjunct Meetings As pe
Page 27 and 28: Scientific Information - Awards The
Page 29 and 30: General Information Lunch and Refre
Page 31: Registration Fees Payment Received:
Page 35 and 36: Exhibitors by Stand Number Stand Co
Page 37 and 38: Exhibitors Listing AGOWA Gesellscha
Page 39 and 40: Exhibitors Listing BIOLOGICAL INDUS
Page 41 and 42: Exhibitors Listing Deerac Fluidics
Page 43 and 44: Exhibitors Listing ESHG - European
Page 45 and 46: Exhibitors Listing Gentra Systems S
Page 47 and 48: Exhibitors Listing Invitrogen Stand
Page 49 and 50: Exhibitors Listing MP Biomedicals S
Page 51 and 52: Exhibitors Listing ParAllele BioSci
Page 53 and 54: Exhibitors Listing SoftGenetics LLC
Page 55 and 56: Plenary Lectures Abstracts PL01. Ga
Page 57 and 58: Concurrent Symposia genes furthers
Page 59 and 60: Concurrent Symposia S09. Immunohist
Page 61 and 62: Concurrent Symposia S21. Ultraconse
Page 63 and 64: Concurrent Sessions the “introduc
Page 65 and 66: Concurrent Sessions (HFE, hemojuvel
Page 67 and 68: Concurrent Sessions generation fami
Page 69 and 70: Concurrent Sessions 5 The KORA grou
Page 71 and 72: Concurrent Sessions exons from two
Page 73 and 74: Concurrent Sessions C43. Interstiti
Page 75 and 76: Concurrent Sessions genetic testing
Page 77 and 78: Concurrent Sessions syndrome phenot
Page 79 and 80: Concurrent Sessions C68. Gene expre
Page 81 and 82: Posters apoE genotype in the model
Page 83 and 84:
Clinical genetics caused by the hom
Page 85 and 86:
Clinical genetics for the disease,
Page 87 and 88:
Clinical genetics examination, he h
Page 89 and 90:
Clinical genetics P0037. A diagnosi
Page 91 and 92:
Clinical genetics processes, genera
Page 93 and 94:
Clinical genetics analysis can be a
Page 95 and 96:
Clinical genetics chromosome 18p an
Page 97 and 98:
Clinical genetics 3 months with int
Page 99 and 100:
Clinical genetics P0084. Intracrani
Page 101 and 102:
Clinical genetics P0094. The Freque
Page 103 and 104:
Clinical genetics Detailed clinical
Page 105 and 106:
Clinical genetics P0113. Short stat
Page 107 and 108:
Clinical genetics P0122. Interleuki
Page 109 and 110:
Clinical genetics P0132. The molecu
Page 111 and 112:
Clinical genetics remains unknown.
Page 113 and 114:
Clinical genetics P0150. A boy with
Page 115 and 116:
Clinical genetics musculoskeletal s
Page 117 and 118:
Clinical genetics cleft soft palate
Page 119 and 120:
Clinical genetics coarse facial fea
Page 121 and 122:
Clinical genetics rearrangements or
Page 123 and 124:
Clinical genetics More than 70 case
Page 125 and 126:
Clinical genetics and the gray matt
Page 127 and 128:
Clinical genetics stains, left-side
Page 129 and 130:
Clinical genetics shiver and hypert
Page 131 and 132:
Clinical genetics suggests it may b
Page 133 and 134:
Clinical genetics remains underdiag
Page 135 and 136:
Clinical genetics acid exchange in
Page 137 and 138:
Clinical genetics as being clinical
Page 139 and 140:
Clinical genetics controversial all
Page 141 and 142:
Cytogenetics The clinical symptoms
Page 143 and 144:
Cytogenetics uniparental disomy pre
Page 145 and 146:
Cytogenetics analysis because of po
Page 147 and 148:
Cytogenetics So, the diagnosis of F
Page 149 and 150:
Cytogenetics Y have been identified
Page 151 and 152:
Cytogenetics P0328. Cytogenetic stu
Page 153 and 154:
Cytogenetics and confirmed by Inter
Page 155 and 156:
Cytogenetics P0347. A complex chrom
Page 157 and 158:
Cytogenetics Estimates of unbalance
Page 159 and 160:
Cytogenetics P0365. A cytogenetic a
Page 161 and 162:
Cytogenetics P0375. Two patients of
Page 163 and 164:
Cytogenetics t(4p;8p) (5 cases), t(
Page 165 and 166:
Cytogenetics from the grandparent.
Page 167 and 168:
Cytogenetics used as markers for ep
Page 169 and 170:
Prenatal diagnosis P0411. Chromosom
Page 171 and 172:
Prenatal diagnosis prenatal diagnos
Page 173 and 174:
Prenatal diagnosis P0429. Character
Page 175 and 176:
Prenatal diagnosis us to perform th
Page 177 and 178:
Prenatal diagnosis P0447. Prenatal
Page 179 and 180:
Prenatal diagnosis P0456. Study of
Page 181 and 182:
Prenatal diagnosis other groups. (m
Page 183 and 184:
Prenatal diagnosis P0474. The analy
Page 185 and 186:
Prenatal diagnosis may be critical
Page 187 and 188:
Cancer genetics same protein. Our r
Page 189 and 190:
Cancer genetics DCC) it seems to ac
Page 191 and 192:
Cancer genetics Western Societies.
Page 193 and 194:
Cancer genetics 98% vs. 98% and 2%
Page 195 and 196:
Cancer genetics Overexpression of S
Page 197 and 198:
Cancer genetics challenges for the
Page 199 and 200:
Cancer genetics a rapid and a non-r
Page 201 and 202:
Cancer genetics In single high risk
Page 203 and 204:
Cancer genetics Conclusions: This e
Page 205 and 206:
Cancer genetics growth rates and re
Page 207 and 208:
Cancer genetics the other gene. We
Page 209 and 210:
Cancer genetics MCR regions). The B
Page 211 and 212:
Cancer genetics spontaneous mitoses
Page 213 and 214:
Cancer genetics P0610. Genomic inst
Page 215 and 216:
Molecular and biochemical basis of
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Genetic analysis, linkage, and asso
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Normal variation, population geneti
Page 341 and 342:
Page 343 and 344:
Page 345 and 346:
Page 347 and 348:
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356:
Page 357 and 358:
Page 359 and 360:
Genomics, technology, gene function
Page 361 and 362:
Page 363 and 364:
Page 365 and 366:
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
Page 373 and 374:
Genetic counselling, education, gen
Page 375 and 376:
Page 377 and 378:
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 385 and 386:
Therapy for genetic disease This wa
Page 387 and 388:
Therapy for genetic disease P1403.
Page 389 and 390:
Author Index A A.D.H. French Res. N
Page 391 and 392:
Author Index 390 Behunova, J. P0014
Page 393 and 394:
Author Index 392 Castro, M. P1067,
Page 395 and 396:
Author Index 394 Dessay, B. P0787 D
Page 397 and 398:
Author Index 396 Frayling, I. P1380
Page 399 and 400:
Author Index 398 Hausmanowa-Petruse
Page 401 and 402:
Author Index 400 Kaya, H. P0545 Kay
Page 403 and 404:
Author Index 402 Lembo, G. P1095 Le
Page 405 and 406:
Author Index 404 Mercader, J. M. S1
Page 407 and 408:
Author Index 406 O'Neill, B. P. P14
Page 409 and 410:
Author Index 408 P0946, P0951, P095
Page 411 and 412:
Author Index 410 Semrád, B. P0831
Page 413 and 414:
Author Index 412 P1309 Taylor, B. P
Page 415 and 416:
Author Index Viot, G. B. P0443 Vipr
Page 417 and 418:
Keyword Index 416 1 10-mer oligonuc
Page 419 and 420:
Keyword Index 418 carcinoma cell li
Page 421 and 422:
Keyword Index 420 DJ-1: P0672 D-Loo
Page 423 and 424:
Keyword Index 422 hemophilia A: P09
Page 425 and 426:
Keyword Index 424 Methylmalonic aci
Page 427 and 428:
Keyword Index 426 Pink1: P0998 pirf
Page 429 and 430:
Keyword Index 428 subtelomeric dele
Page 431 and 432:
Notes 430
Page 433:
Notes 432
show all

2005 Prague - European Society of Human Genetics

Create successful ePaper yourself

Delete template?

Save as template?